HIGHLIGHTS
- who: Philippine Eloy from the ^pital Bichat Claude Bernard, France have published the Article: Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?, in the Journal: (JOURNAL) of 18/Oct/2021
SUMMARY
Received a clinical benefit in hospitalized patients. In outpatients, molnupiravir reduces the risk of hospitalization or death by approximately 50 percent compared to placebo for patients with mild or moderate COVID19 in an interim analysis of phase III study. The study of Abdelnabi et_al builds on previous pre-clinical studies that showed a marked activity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.